• Explore /
  • Poster
  • / Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.

Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.

Abstract Poster

Authors

Benjamin Weinberg

Benjamin Adam Weinberg

Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC

Benjamin Adam Weinberg , Alexander Lekan , Allison Fitzgerald , Zoe Malchiodi , Martin Gutierrez , Anteneh A. Tesfaye , Ming Tony Tan , Marcus Smith Noel , Aiwu Ruth He , Reetu Mukherji , John Marshall , Princess Jones , Pascal Borderies , Vincent O'Neill , Louis M. Weiner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT05558982

Citation

J Clin Oncol 42, 2024 (suppl 17; abstr LBA4132)

DOI

10.1200/JCO.2024.42.17_suppl.LBA4132

Abstract #

LBA4132

Poster Bd #

112

Abstract Disclosures

Similar Posters

First Author: Benjamin Adam Weinberg

First Author: Shipra Gandhi

First Author: Anser Ali Abbas

First Author: Sumit Kumar Subudhi